1 | prostadoz® cp pell b30 | | | | | | | 4 | 0.69% |
2 | viasart 160mg b30 comp | | | | | | | 3 | 0.52% |
3 | 55 microgrammes par dose | | | | | | | 3 | 0.52% |
4 | nasadoze 55 microgrammes par | | | | | | | 3 | 0.52% |
5 | de 30boite de 90 | | | | | | | 3 | 0.52% |
6 | boite de 30boite de | | | | | | | 3 | 0.52% |
7 | 80mg b30 comp pelli | | | | | | | 3 | 0.52% |
8 | viasart 80mg b30 comp | | | | | | | 3 | 0.52% |
9 | cardiologie et angeiologie world | | | | | | | 2 | 0.35% |
10 | flavonoides exprimes en hesperidine | | | | | | | 2 | 0.35% |
11 | comprimé boite de 30boite | | | | | | | 2 | 0.35% |
12 | mg comprimé boite de | | | | | | | 2 | 0.35% |
13 | 100 mg comprimé boite | | | | | | | 2 | 0.35% |
14 | aspinova® 100 mg comprimé | | | | | | | 2 | 0.35% |
15 | trading nasadoze 55 microgrammes | | | | | | | 2 | 0.35% |
16 | purifiee micronisee soit en | | | | | | | 2 | 0.35% |
17 | novapharm trading nasadoze 55 | | | | | | | 2 | 0.35% |
18 | 160mg b30 comp pelli | | | | | | | 2 | 0.35% |
19 | flavonoique purifiee micronisee soit | | | | | | | 2 | 0.35% |
20 | suspension pour pulvérisation nasale | | | | | | | 2 | 0.35% |
21 | mg comprimé dispersible sécable | | | | | | | 2 | 0.35% |
22 | suspension pour pulvÉrisation nasale | | | | | | | 2 | 0.35% |
23 | 2 mg comprimé dispersible | | | | | | | 2 | 0.35% |
24 | novagenerics® 2 mg comprimé | | | | | | | 2 | 0.35% |
25 | neobiol 100mg comprimé pelliculé | | | | | | | 2 | 0.35% |
26 | betamethasone novagenerics® 2 mg | | | | | | | 2 | 0.35% |
27 | fraction flavonoique purifiee micronisee | | | | | | | 2 | 0.35% |
28 | trading flavon 500 mg | | | | | | | 2 | 0.35% |
29 | cp pell b30 prostadoz® | | | | | | | 2 | 0.35% |
30 | pell b30 prostadoz® cp | | | | | | | 2 | 0.35% |
31 | novapharm trading flavon 500 | | | | | | | 2 | 0.35% |
32 | b30 prostadoz® cp pell | | | | | | | 2 | 0.35% |
33 | et angeiologie world medicine | | | | | | | 2 | 0.35% |
34 | angeiologie world medicine viasart | | | | | | | 2 | 0.35% |
35 | world medicine viasart 160mg | | | | | | | 2 | 0.35% |
36 | dcivalsartan cthérapeutiquecardiologie et angeiologie | | | | | | | 2 | 0.35% |
37 | b30 comp pelli valsartan | | | | | | | 2 | 0.35% |
38 | medicine viasart 160mg b30 | | | | | | | 2 | 0.35% |
39 | medicine viasart 80mg b30 | | | | | | | 2 | 0.35% |
40 | world medicine viasart 80mg | | | | | | | 2 | 0.35% |